We use first and third-party cookies to offer our services and collect statistical data. If you continue browsing this website you accept their use. More information Accept
PRODUCTS / CNS PHARMACEUTICALS
CNS_PHARMA_METAS_SERVICE_ALT

CNS PHARMACEUTICALS

Lesvi offers one of the most comprehensive product portfolios in CNS pharmaceuticals.
Product Indication Dosage form Strength
Amitriptyline Major depressive disorders and anxiety Tablets 10, 25, 50, 75 and 100 mg
Amitriptyline Major depressive disorders and anxiety XR tablets 75 mg
Clonazepam Epilepsy Tablets 0.5 mg and 2 mg
Eslicarbazepine Epilepsy Film-coated tablets 800 mg
Fampridine Multiple sclerosis XR tablets 10 mg
Fingolimod Multiple sclerosis Capsules 0.5 mg
Methocarbamol Muscle spasms, pain Film-coated tablets 1.5 mg
Pyridostigmine Myasthenia gravis Film-coated tablets 60 mg
Quetiapine Psychosis, schizophrenia, bipolar disoder Orodispersable tablets 25 and 50 mg
Rotigotine Parkinson's Patches 1, 2, 3, 4, 6 and 8 mg/24h
Sodium Oxybate Narcolepsy Oral solution 500 mg/ml
FDF PRODUCT PORTFOLIO

[S] Singular Generics

Listed products protected by valid patents are developed solely for purposes related to the development, preparation and submission of information to obtain a Marketing Authorisation. In particular these products are under development for uses related to the activities stated in Art. 10.6 of Directive 2001/83/EC amended by the Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004, i.e. activities carried out to obtain a Marketing Authorisation. None of the products are offered for sale or supplied to countries in which they could be in conflict with valid patents.


© Neuraxpharm / LESVI. All rights reserved.